Another Notch to be added to the list of hepatocellular growth regulatory factors?
S. Hübscher,A. Strain
DOI: https://doi.org/10.1002/hep.20640
IF: 17.298
2005-03-01
Hepatology
Abstract:Signaling pathways involving the Notch receptor system play a critical role in mediating cell-cell interactions which determine cell fate and organ development in a wide variety of organisms, including insects, nematode worms, echinoderms, and mammals.1,2 Signaling is activated when Notch receptors, which are present as transmembrane proteins bind to ligands, also present as transmembrane proteins on adjacent cells. In humans, four Notch receptors (Notch-1, -2, -3, and -4) and five ligands (Jagged-1 and -2, and Delta-1, -3, and -4) have been identified.3 Notch signaling can also modulate apoptosis and cell proliferation.1,4 Notch receptor and ligand proteins are constitutively expressed in various human tissues, including the liver. In human fetal liver, interactions between Jagged-1, expressed on the embryonic ductal plate, and Notch-3, expressed on the adjacent portal tract mesenchyme and hepatic arterial endothelium, are thought to play a role in the process of ductal plate remodeling and the subsequent development of the intrahepatic biliary tree.5 This suggestion is supported by the discovery that mutations of the Jagged-1 gene are present in the majority of patients with Alagille syndrome (AGS),6,7 a disease characterized by defective development of interlobular bile ducts. In the normal human liver, expression of Notch-1, -2 and -3 receptors and Jagged-1 ligand has been observed to varying degrees on bile ducts, hepatic artery and/or portal vein endothelium, and hepatocytes.8-10 Altered expression of Notch receptor/ligand genes and proteins has also been described in a range of pediatric and adult liver diseases,5,9-12 including expression on reactive bile ductules and small neovessels, both of which are thought to be important in the pathogenesis of the progressive periportal fibrosis that occurs in chronic cholestatic liver diseases associated with bile duct loss. In experimental studies using mouse knockout models, Notch-1, Notch-2, and Jagged-1 have all been shown to be essential for normal embryonic development. Animals in which expression of these genes is disrupted die in utero, frequently from vascular defects.13-16 The development of suitable animal models for investigating defects in Notch signaling has thus been difficult. One notable exception is a mouse model of AGS in which animals doubly heterozygous for Jagged-1 and Notch-2 mutations developed a syndrome closely resembling AGS, including defective development of intrahepatic bile ducts.17 Jagged/Notch interactions have also been implicated in bile duct development in the normal mouse fetal liver, with upregulation of Notch-2 on hepatoblasts being associated with differentiation toward a biliary phenotype.18-20 Thus, while there is increasing evidence to suggest that the Notch signaling pathway is important in the development of intrahepatic bile ducts and blood vessels in health and disease, less is known about the role of the Notch signaling pathway in hepatocyte development and homeostasis, although in one study downregulation of Notch-2 expression on fetal mouse hepatoblasts appeared to be associated with hepatocellular differentiation.19 The paper by Croquelois and colleagues in this issue of HEPATOLOGY describes interesting novel observations, which provide a further insight into our understanding of the complex and important Notch signaling pathway.21 A previously developed mouse model was used in which inactivation of Notch-1 can be conditionally induced postnatally in mice with a defective but non-lethal Notch-1 mutation.22 In contrast to the Jagged-1/Notch-2 double heterozygous mouse model of AGS in which intrahepatic bile duct development was defective,17 bile ducts in the conditional Notch-1–deficient mice were well preserved and displayed a normal proliferative capacity in response to partial hepatectomy and bile duct ligation. Surprisingly, however, there was an 8-fold increase in hepatocellular proliferation in the Notch-1–deficient mice compared with normal controls, resulting in a 40% increase in liver mass relative to body weight. This was associated with downregulation of Notch-1 expression on hepatocytes and with histological features of nodular regenerative hyperplasia (NRH). Abbreviations: AGS, Alagille syndrome; NRH, nodular regenerative hyperplasia; NIC, Notch intracellular domain; LFng, Lunatic Fringe; MFng, Manic Fringe; RFng, Radical Fringe; TNF, tumor necrosis factor; IL-6, interleukin-6; VEGF, vascular endothelial growth factor; IGF, insulin-like growth factor; HCC, hepatocellular carcinoma. Address reprint requests to: S.G. Hübscher, Department of Pathology, University of Birmingham, Birmingham B15 2TT, United Kingdom. E-mail: s.g.hubscher@bham.ac.uk; fax: (44) 0121-414-4019. Copyright © 2005 by the American Association for the Study of Liver Diseases. Published online in Wiley InterScience (www.interscience.wiley.com). DOI 10.1002/hep.20640 Conflict of interest: Nothing to report.